Live feed
·
PRReleasevia Quantisnow
Cardiff Oncology Inc. logo

Cardiff Oncology to Present Preclinical Data with Highly Specific PLK1 Inhibitor Onvansertib at the 2026 AACR Annual Meeting

ByQuantisnow·Wall Street's wire, on your screen.
CRDF· Cardiff Oncology Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRDF (Cardiff Oncology Inc.) and more on Quantisnow.